Activation of kcnq4 as a therapeutic strategy to treat hearing loss

John Hoon Rim, Jae Young Choi, Jinsei Jung, Heon Yung Gee

Research output: Contribution to journalReview articlepeer-review

Abstract

Potassium voltage‐gated channel subfamily q member 4 (KCNQ4) is a voltage‐gated potassium channel that plays essential roles in maintaining ion homeostasis and regulating hair cell membrane potential. Reduction of the activity of the KCNQ4 channel owing to genetic mutations is responsible for nonsyndromic hearing loss, a typically late‐onset, initially high‐frequency loss progressing over time. In addition, variants of KCNQ4 have also been associated with noise‐induced hearing loss and age‐related hearing loss. Therefore, the discovery of small compounds activating or potentiating KCNQ4 is an important strategy for the curative treatment of hearing loss. In this review, we updated the current concept of the physiological role of KCNQ4 in the inner ear and the pathologic mechanism underlying the role of KCNQ4 variants with regard to hearing loss. Finally, we focused on currently developed KCNQ4 activators and their pros and cons, paving the way for the future development of specific KCNQ4 activators as a remedy for hearing loss.

Original languageEnglish
Article number2510
Pages (from-to)1-12
Number of pages12
JournalInternational journal of molecular sciences
Volume22
Issue number5
DOIs
Publication statusPublished - 2021 Mar 1

Bibliographical note

Funding Information:
This research was supported by the Bio and Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science and ICT (NRF?2019M3E5D5066690 and 2018R1A5A2025079).

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

All Science Journal Classification (ASJC) codes

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Fingerprint Dive into the research topics of 'Activation of kcnq4 as a therapeutic strategy to treat hearing loss'. Together they form a unique fingerprint.

Cite this